Comments on: OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing AKR1C3

Comments on: OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing AKR1C3 https://www.worldpharmatoday.com/drug-research/obi-pharma-to-develop-obi-3424-previously-th-3424-as-a-potential-treatment-of-cancers-expressing-akr1c3/ Magazine for the C-level Pharma Executives Thu, 01 Jun 2017 11:06:26 +0000 hourly 1 https://wordpress.org/?v=6.9.4